INTEGRASYN
DEAD

Serial Number

88873708

Owner

InMed Pharmaceuticals Inc.

Attorney

Joseph P. Grasser

Filing Date

Apr 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

INTEGRASYN Trademark

Serial Number: 88873708

INTEGRASYN is a trademark filed by InMed Pharmaceuticals Inc. on April 15, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

InMed Pharmaceuticals Inc.

Vancouver BC V6C1B4 , CA

Entity Type: 03

Trademark Details

Filing Date

April 15, 2020

Registration Date

Not Registered

Published for Opposition

August 11, 2020

Goods & Services

Custom manufacture of chemicals; Contract manufacturing in the field of chemicals; Custom manufacture of pharmaceuticals and biopharmaceutical drugs; Custom manufacturing of new biological products for others; Biomanufacturing for others, namely, manufacturing of pharmaceuticals and biopharmaceutical drugs using biological organisms in the manufacturing process; Custom manufacture of nutraceuticals for others; Custom manufacture of cosmeceuticals for others; Custom manufacture of medical veterinary products for others; research in the field of manufacturing processes

Pharmaceutical and biopharmaceutical preparations and substances for the treatment of pain, inflammation, cancer, neurological disorders, seizures, epilepsy, Alzheimer's disease, Parkinson's disease, multiple sclerosis, muscular dystrophy, anxiety, sleep disorders, mood and behavioral disorders, gastro-intestinal diseases, nausea, vomiting, ocular disorders, glaucoma, skin and dermatological disorders, and epidermolysis bullosa

Research and development of new products; Research and development of new biological products for others; Research and development of new chemical products for others; Pharmaceutical research and development; Biochemical research and development; Research and development of pharmaceuticals and biopharmaceutical drugs; Development of pharmaceutical preparations and medicines; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering, and organic chemistry

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 6, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 6, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 5, 2023 EXRA
SOU EXTENSION 5 GRANTED
Apr 4, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 4, 2023 AITU
SOU EXTENSION 5 FILED
Mar 27, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 27, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 5, 2022 EXRA
SOU EXTENSION 4 GRANTED
Oct 3, 2022 EX4G
SOU EXTENSION 4 FILED
Oct 3, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 3, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 30, 2022 EXRA
SOU EXTENSION 3 GRANTED
Mar 28, 2022 EX3G
SOU EXTENSION 3 FILED
Mar 28, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 28, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 23, 2021 EXRA
SOU EXTENSION 2 GRANTED
Sep 21, 2021 EX2G
SOU EXTENSION 2 FILED
Sep 21, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 21, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 18, 2021 EXRA
SOU EXTENSION 1 GRANTED
Mar 16, 2021 EX1G
SOU EXTENSION 1 FILED
Mar 16, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 16, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 6, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 11, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 9, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 7, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 7, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 7, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 7, 2020 CNEA
ASSIGNED TO EXAMINER
Jul 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 24, 2020 NWOS
NEW APPLICATION ENTERED
Apr 18, 2020 NWAP